GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Median Diagnostics Inc (XKRX:233250) » Definitions » Asset Turnover

Median Diagnostics (XKRX:233250) Asset Turnover : 0.55 (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Median Diagnostics Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Median Diagnostics's Revenue for the six months ended in Dec. 2024 was ₩12,194 Mil. Median Diagnostics's Total Assets for the quarter that ended in Dec. 2024 was ₩22,194 Mil. Therefore, Median Diagnostics's Asset Turnover for the quarter that ended in Dec. 2024 was 0.55.

Asset Turnover is linked to ROE % through Du Pont Formula. Median Diagnostics's annualized ROE % for the quarter that ended in Dec. 2024 was 12.18%. It is also linked to ROA % through Du Pont Formula. Median Diagnostics's annualized ROA % for the quarter that ended in Dec. 2024 was 10.83%.


Median Diagnostics Asset Turnover Historical Data

The historical data trend for Median Diagnostics's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Median Diagnostics Asset Turnover Chart

Median Diagnostics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.77 0.69 1.07 0.52 0.55

Median Diagnostics Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.77 0.69 1.07 0.52 0.55

Competitive Comparison of Median Diagnostics's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Median Diagnostics's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Median Diagnostics's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Median Diagnostics's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Median Diagnostics's Asset Turnover falls into.


;
;

Median Diagnostics Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Median Diagnostics's Asset Turnover for the fiscal year that ended in Dec. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=12194.441/( (21723.872+22664.488)/ 2 )
=12194.441/22194.18
=0.55

Median Diagnostics's Asset Turnover for the quarter that ended in Dec. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Dec. 2024 ))/ count )
=12194.441/( (21723.872+22664.488)/ 2 )
=12194.441/22194.18
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Median Diagnostics  (XKRX:233250) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Median Diagnostics's annulized ROE % for the quarter that ended in Dec. 2024 is

ROE %**(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=2403.922/19739.5205
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(2403.922 / 24388.882)*(24388.882 / 22194.18)*(22194.18/ 19739.5205)
=Net Margin %*Asset Turnover*Equity Multiplier
=9.86 %*1.0989*1.1244
=ROA %*Equity Multiplier
=10.83 %*1.1244
=12.18 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2024) net income data. The Revenue data used here is two times the semi-annual (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Median Diagnostics's annulized ROA % for the quarter that ended in Dec. 2024 is

ROA %(Q: Dec. 2024 )
=Net Income/Total Assets
=2403.922/22194.18
=(Net Income / Revenue)*(Revenue / Total Assets)
=(2403.922 / 24388.882)*(24388.882 / 22194.18)
=Net Margin %*Asset Turnover
=9.86 %*1.0989
=10.83 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2024) net income data. The Revenue data used here is two times the semi-annual (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Median Diagnostics Asset Turnover Related Terms

Thank you for viewing the detailed overview of Median Diagnostics's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Median Diagnostics Business Description

Traded in Other Exchanges
N/A
Address
878 Seoul Office, Dongnae-dong, Kangwon-do, Chuncheon, KOR, 200-883
Median Diagnostics Inc is a Korea based company engaged in providing IVD solutions and veterinary diagnostics services. Its solutions portfolio covers avian influenza diagnosis solution, foot and mouth disease diagnosis solution, African Pig fever solution and others. The company offers ELISA diagnostic products, rapid test kit, molecular diagnosis products, standard diagnosis products and biologicals.

Median Diagnostics Headlines

No Headlines